Cargando…
Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach
Capecitabine, a fluoropyrimidine prodrug, has been a frequently chosen ligand for the last one and half decades to inhibit thymidylate synthase (TYMS) for treatment of colorectal cancer. TYMS is a key enzyme for de novo synthesis of deoxythymidine monophosphate and subsequent synthesis of DNA. Recen...
Autores principales: | Rahman, Adhip, Hoque, Mohammad Mazharol, Khan, Mohammad A. K., Sarwar, Mohammed G., Halim, Mohammad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764604/ https://www.ncbi.nlm.nih.gov/pubmed/27026843 http://dx.doi.org/10.1186/s40064-016-1844-y |
Ejemplares similares
-
Inhibition of DNA Topoisomerase Type IIα (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study
por: Abu Saleh, Md., et al.
Publicado: (2016) -
Halogen-directed drug design for Alzheimer’s disease: a combined density functional and molecular docking study
por: Rahman, Adhip, et al.
Publicado: (2016) -
First Case of Foot Drop Associated with Capecitabine in a Patient with Thymidylate Synthase Polymorphism
por: Wilks, Andrew B, et al.
Publicado: (2017) -
Effect of Hammerhead Ribozyme against Human Thymidylate Synthase on the Cytotoxicity of Thymidylate Synthase Inhibitors
por: Kobayashi, Hiroyuki, et al.
Publicado: (1995) -
Visfatin and Resveratrol Differentially Regulate the Expression of Thymidylate Synthase to Control the Sensitivity of Human Colorectal Cancer Cells to Capecitabine Cytotoxicity
por: Wu, Kuen-Lin, et al.
Publicado: (2021)